SG Americas Securities LLC Acquires New Position in Vivid Seats Inc. (NASDAQ:SEAT)

SG Americas Securities LLC acquired a new stake in Vivid Seats Inc. (NASDAQ:SEAT) in the third quarter, Holdings Channel reports. The firm acquired 34,156 shares of the company’s stock, valued at approximately $126,000.

A number of other institutional investors have also recently made changes to their positions in SEAT. Allspring Global Investments Holdings LLC purchased a new position in Vivid Seats in the first quarter worth approximately $230,000. Capstone Investment Advisors LLC lifted its stake in Vivid Seats by 192.4% in the first quarter. Capstone Investment Advisors LLC now owns 149,103 shares of the company’s stock worth $893,000 after acquiring an additional 98,103 shares during the last quarter. Oppenheimer & Co. Inc. purchased a new position in Vivid Seats in the first quarter worth approximately $264,000. Swiss National Bank lifted its stake in Vivid Seats by 14.0% in the first quarter. Swiss National Bank now owns 132,100 shares of the company’s stock worth $791,000 after acquiring an additional 16,200 shares during the last quarter. Finally, Entropy Technologies LP purchased a new position in Vivid Seats in the first quarter worth approximately $101,000. Institutional investors and hedge funds own 39.92% of the company’s stock.

Vivid Seats Stock Down 0.5 %

SEAT stock opened at $3.92 on Friday. The company has a fifty day moving average price of $4.09 and a 200 day moving average price of $4.80. Vivid Seats Inc. has a 12 month low of $3.36 and a 12 month high of $8.80. The company has a market cap of $815.67 million, a price-to-earnings ratio of 7.18, a price-to-earnings-growth ratio of 16.06 and a beta of 1.21. The company has a debt-to-equity ratio of 2.48, a current ratio of 0.79 and a quick ratio of 0.73.

Vivid Seats (NASDAQ:SEAT) last released its quarterly earnings results on Tuesday, August 6th. The company reported ($0.01) EPS for the quarter, missing the consensus estimate of $0.07 by ($0.08). Vivid Seats had a net margin of 4.73% and a return on equity of 57.44%. The business had revenue of $198.32 million during the quarter, compared to analysts’ expectations of $194.68 million. During the same quarter last year, the company earned $0.20 EPS. Sell-side analysts expect that Vivid Seats Inc. will post 0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Citigroup decreased their price target on shares of Vivid Seats from $10.00 to $9.00 and set a “buy” rating for the company in a research note on Friday, September 20th. Royal Bank of Canada reduced their price objective on shares of Vivid Seats from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Wednesday, August 7th. DA Davidson reduced their price objective on shares of Vivid Seats from $6.50 to $6.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Piper Sandler reduced their price objective on shares of Vivid Seats from $7.00 to $5.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Vivid Seats from $5.50 to $4.50 and set a “hold” rating for the company in a research report on Monday, August 12th. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $7.28.

Vivid Seats Profile

Vivid Seats Inc operates an online ticket marketplace in the United States, Canada, and Japan. The company operates in two segments, Marketplace and Resale. The Marketplace segment acts as an intermediary between event ticket buyers and sellers; processes ticket sales on its website and mobile applications through its distribution partners; and sells tickets for sports, concerts, theater events, and other live events.